Search

Search Constraints

You searched for: Author/Creator Forstpointner, Roswitha

Search Results

1. Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group. Issue 7 (23rd July 2021)

2. Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) – A case series. (October 2022)

3. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Issue 10044 (6th August 2016)

4. Primary effusion lymphoma (PEL) without effusion: a patient case report of a PEL solid variant. Issue 2 (19th October 2011)